Encompass Health closed at $134.79 on Nov 3, down 1.75%, 1.7% below its 52-week closing high. Volume of 1.4M shares was 1.17× its 20-day average (close to normal).
Split-adjusted performance: +11.4% over one month, +28.2% over six months, +18.4% over one year.
In the quarter ended Jun 30, 2026, revenue was $1.60B, up 9.6% from a year earlier, with a net margin of 9.6%.
Short interest was 3.3M shares at the Oct 15 settlement, down 5.0% from the prior report (3.4% of float, 3.5 days to cover).